| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Puma Biotechnology, Inc. (PBYI) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. PBYI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 227.5K | $1.80M | - | |
| Other | 70.3K | $556.9K | - | |
| CFO | 66.5K | $527.0K | - | |
| Dir | 54.0K | $427.7K | - | |
| Dir | 41.9K | $331.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 97 | $7.81 | $757.57 | -0.1% | |
| Nov 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 371 | $7.82 | $2,899.40 | - | |
| Oct 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 350 | $10.13 | $3,544.80 | - | |
| Oct 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 91 | $10.14 | $923.10 | -0.1% | |
| Sep 16, 2020 | Moyes Jay M49 | Director | Sell | 9,703 | $10.00 | $97,030.00 | -23.5% | |
| Sep 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 90 | $9.77 | $879.30 | -0.1% | |
| Sep 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 347 | $9.78 | $3,393.35 | - | |
| Aug 3, 2020 | Bryce Richard Paul | See Remarks | Sell | 86 | $10.80 | $928.80 | -0.1% | |
| Aug 3, 2020 | Auerbach Alan H62 | President And CEO | Sell | 330 | $10.79 | $3,560.70 | - | |
| Jul 2, 2020 | Hunt Douglas M62 | See Remarks | Sell | 572 | $10.69 | $6,111.82 | -1.0% |